Position in GRFS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$211,195
+$79,516 QoQ
Shares Held
29,830
+81.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 164 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in GRFS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,195 | 29,830 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $131,679 | 16,419 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $139,388 | 14,908 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $136,869 | 13,742 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $97,333 | 10,767 | Shares | Defined | 2025-08-05 | |
| 2023-09-30 | $96,801 | 10,591 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,796,135 | 305,255 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,207,660 | 299,547 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,514,205 | 295,789 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,908,545 | 309,829 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,165,292 | 350,614 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,077,252 | 349,080 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,278,269 | 380,968 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,565,604 | 380,945 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $7,031,657 | 405,283 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $9,271,968 | 536,262 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $11,993,356 | 650,399 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $11,990,774 | 691,111 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,557,381 | 688,453 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $14,672,410 | 728,521 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||